Progeria is a rare genetic disorder that causes children to age rapidly and rarely reach their teenage years. Affected children go bald at an early age, their growth stops, they lose weight, and they develop stiff joints, wrinkled skin, bone loss and atherosclerosis. This is caused by a gene mutation that stimulates the production of the protein progerin, which leads to rapid ageing. Around 400 people worldwide suffer from Hutchinson–Gilford progeria syndrome.
Mice with this gene mutation have now been treated using a variant of the CRISPR gene-editing tool. This prevented heart damage associated with the genetic defect. The progeria mice treated by the researchers survived for 500 days – more than twice as long as their untreated counterparts and more than half as long as healthy mice. The modified DNA was found in 20 to 60 per cent of the mice’s bones, skeletal muscles, liver and heart. Although the mice were already five years old in human years at the start of the experiment, their aortas and muscles showed almost no signs of progeria-related damage.
An incredible result – especially given that previous approaches had yielded only limited success. “This exceeds all expectations and cries out for application in children with progeria – and within the next three years,” says genome-editing expert Fyodor Urnov from the University of California, Berkeley.
Study co-author Leslie Gordon, whose son Sam died of progeria and who founded the Progeria Research Foundation, does not want to wait for a second round of trials and intends to start immediately to secure funding for trials involving children. “We will find a way,” she explains, “because these children have no time to lose.”
References:
Harvard University; National Institutes of Health, Bethesda
. In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice, Nature 2021: 6967:491
https://www.nature.com/articles/s41586-020-03086-7